Developments in health technology allow us to take more personal responsibility for our wellbeing, which may have significant ...

Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.

For individuals with type 1 diabetes, low-glucose alerts improve the time below range for drivers and reduce the inci ...

The No. 1 reason physicians cite for not prescribing a continuous glucose monitor is its complexity, a roadblock that DME ...

The latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people ...

CMA CGM confirmed that it has submitted its bid to the Enterprise Court of Brussels. It therein focuses solely on the Belgian carrier’s cargo activities, including its aircraft. The step comes after ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

The diabetes market is booming, and Thermo Fisher Scientific is seizing the opportunity, positioning itself as a leader in ...

The diabetes market is booming, with continuous glucose monitoring (CGM) and GLP-1 drugs leading the charge in innovation and ...

Check your alert settings and refer to your device's manual to ensure the alerts are working as expected. Some people who use continuous glucose monitors have reported not receiving or hearing safety ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...